Showing 147,921 - 147,940 results of 227,950 for search '(( 2 step decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (nn decrease)))) ))', query time: 2.32s Refine Results
  1. 147921
  2. 147922

    Image_1_Multi-System Adaptation to Confinement During the 180-Day Controlled Ecological Life Support System (CELSS) Experiment.jpeg by Ming Yuan (90012)

    Published 2019
    “…Carotid intima-media thickness (IMT) increased by 10–15%. Endothelium-dependent vasodilation decreased. …”
  3. 147923

    Image_3_Multi-System Adaptation to Confinement During the 180-Day Controlled Ecological Life Support System (CELSS) Experiment.jpeg by Ming Yuan (90012)

    Published 2019
    “…Carotid intima-media thickness (IMT) increased by 10–15%. Endothelium-dependent vasodilation decreased. …”
  4. 147924

    Image_4_Multi-System Adaptation to Confinement During the 180-Day Controlled Ecological Life Support System (CELSS) Experiment.jpeg by Ming Yuan (90012)

    Published 2019
    “…Carotid intima-media thickness (IMT) increased by 10–15%. Endothelium-dependent vasodilation decreased. …”
  5. 147925

    Data_Sheet_1_Multi-System Adaptation to Confinement During the 180-Day Controlled Ecological Life Support System (CELSS) Experiment.zip by Ming Yuan (90012)

    Published 2019
    “…Carotid intima-media thickness (IMT) increased by 10–15%. Endothelium-dependent vasodilation decreased. …”
  6. 147926

    Image_2_Multi-System Adaptation to Confinement During the 180-Day Controlled Ecological Life Support System (CELSS) Experiment.jpeg by Ming Yuan (90012)

    Published 2019
    “…Carotid intima-media thickness (IMT) increased by 10–15%. Endothelium-dependent vasodilation decreased. …”
  7. 147927

    image1_Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.tif by Jinmei Su (4604059)

    Published 2020
    “…</p><p>Results: This subanalysis revealed no significant difference between the patient groups treated with HS016 or adalimumab for any individual efficacy indicator investigated at any time point (all p > 0.05) beside faster total back pain score improvements in the adalimumab group on week 10, 12 and 22, which became equal at week 24. Among these indicators, chest expansion showed a significant increase at each time point compared with baseline, whereas all other efficacy indicators showed significant decreases compared with baseline at each time point (all p < 0.05). …”
  8. 147928
  9. 147929
  10. 147930
  11. 147931
  12. 147932
  13. 147933

    Presentation1_Pulmonary nitric oxide in astronauts before and during long-term spaceflight.pdf by Lars L. Karlsson (17875562)

    Published 2024
    “…</p><p>Results: The levels of PENO at 50 mL/s (PENO50) were not stable during the preflight and inflight periods respectively but decreased with time (p = 0.0284) at a rate of 0.55 (0.24) [mean (SD)] mPa per 180 days throughout the observation period, so that there was a significant difference (p < 0.01, N = 10) between gravity conditions. …”
  14. 147934
  15. 147935
  16. 147936
  17. 147937
  18. 147938
  19. 147939
  20. 147940